Simulated Driving and Attention of Repeat Users of MDMA and THC Compared with THC Users and Non-Drug-Using Controls
暂无分享,去创建一个
Matthew Rizzo | Antoine Bechara | A. Bechara | M. Rizzo | J. Ramaekers | C. Lamers | Caroline T. J. Lamers | Jan Ramaekers
[1] A. García-Osta,et al. Differential Regulation by Methylenedioxymethamphetamine of 5‐Hydroxytryptamine1A Receptor Density and mRNA Expression in Rat Hippocampus, Frontal Cortex, and Brainstem: The Role of Corticosteroids , 1997, Journal of neurochemistry.
[2] E. Gouzoulis-Mayfrank,et al. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) , 2000, Journal of neurology, neurosurgery, and psychiatry.
[3] A. Lees,et al. Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits , 1998, Journal of psychopharmacology.
[4] G. Guyatt,et al. The independent contribution of driver, crash, and vehicle characteristics to driver fatalities. , 2002, Accident; analysis and prevention.
[5] J. Robinson,et al. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? , 2001, Psychopharmacology.
[6] J. Rodgers,et al. Cognitive performance amongst recreational users of "ecstasy , 2000, Psychopharmacology.
[7] Y. Shaham,et al. Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans , 1994, Neuropsychopharmacology.
[8] M. Rizzo,et al. Motion and shape perception in cerebral akinetopsia. , 1995, Brain : a journal of neurology.
[9] U. McCann,et al. Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy") , 2002, Science.
[10] M. Sloane,et al. Visual processing impairment and risk of motor vehicle crash among older adults. , 1998, JAMA.
[11] A. Young,et al. A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field , 2002, Psychopharmacology.
[12] P C Dischinger,et al. Effect of change in velocity on the development of medical complications in patients with multisystem trauma sustained in vehicular crashes. , 1998, Accident; analysis and prevention.
[13] L. Chait,et al. Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance , 1994, Psychopharmacology.
[14] D Mahalel,et al. Driver's decision process on termination of the green light. , 1985, Accident; analysis and prevention.
[15] J. Krystal,et al. Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? , 1992, The American journal of drug and alcohol abuse.
[16] S. Vecera,et al. Psychoanatomical substrates of Bálint's syndrome , 2002, Journal of neurology, neurosurgery, and psychiatry.
[17] A. Bechara,et al. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls , 2006, Journal of psychopharmacology.
[18] J. Alvarez,et al. Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: relationships with impulsivity and depression. , 2001, Life sciences.
[19] M. Morgan. Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity , 1998, Neuropsychopharmacology.
[20] I. Deary,et al. The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year interval , 2001, Psychological Medicine.
[21] Rodney J. Croft,et al. The relative contributions of ecstasy and cannabis to cognitive impairment , 2001, Psychopharmacology.
[22] M. Wheaton,et al. THE EFFECTS OF METHYLENEDIOXYMETHAMPHETAMINE (MDMA, “ECSTASY”) ON MONOAMINERGIC NEUROTRANSMISSION IN THE CENTRAL NERVOUS SYSTEM , 1996, Progress in Neurobiology.
[23] M. Colado,et al. Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration , 1999, Psychopharmacology.
[24] C. Owsley,et al. Vision and Driving in the Elderly , 1994, Optometry and vision science : official publication of the American Academy of Optometry.
[25] M Mäntyjärvi,et al. Normal values for the Pelli‐Robson contrast sensitivity test , 2001, Journal of cataract and refractive surgery.
[26] J. V. van Gerven,et al. Cognitive performance and serotonergic function in users of ecstasy , 2000, Psychopharmacology.
[27] M. Rizzo,et al. Simulated Car Crashes and Crash Predictors in Drivers With Alzheimer Disease , 1997 .
[28] M. Rizzo,et al. Simulated Car Crashes at Intersections in Drivers With Alzheimer Disease , 2001, Alzheimer disease and associated disorders.
[29] A. Parrott. Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research , 2001, Human psychopharmacology.
[30] J. Cadet,et al. Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms , 2003, Brain Research Reviews.
[31] J. Fisk,et al. Working memory deficits in current and previous users of MDMA ('ecstasy'). , 2000, British journal of psychology.
[32] U. McCann,et al. (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies , 2000, Neuropsychobiology.
[33] S. Heishman,et al. Acute and Residual Effects of Marijuana in Humans , 1998, Pharmacology Biochemistry and Behavior.
[34] L. Chait. Subjective and behavioral effects of marijuana the morning after smoking , 2005, Psychopharmacology.
[35] U. McCann,et al. Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study , 1999, Psychopharmacology.
[36] D. Olton,et al. 3,4-Methylenedioxymethamphetamine, serotonin and memory. , 1993, The Journal of pharmacology and experimental therapeutics.